Interventional angiography C-arm suite for hepatic artery infusion chemotherapy

LIVER & BILE DUCT CANCER CARE

Advanced Liver Cancer Care in China

Liver cancer often develops quietly and is frequently diagnosed at an advanced stage or near major blood vessels. China has built the world’s most experienced liver cancer care teams, pioneering specialized techniques that shrink large, previously inoperable tumors down to a size where they can be safely removed or cured.

  • Primary Liver Cancer (HCC) & Bile Duct Cancers (Cholangiocarcinoma)
  • Large Tumors or Cancers Involving Critical Blood Vessels (Portal Vein)
  • Patients Told Their Tumors Are Inoperable or Beyond Standard Chemo
  • World's Highest Surgical Volume for Complex Liver Operations
  • Specialized Direct-Artery Tumor Infusion (HAIC) & Particle Radiation
  • Continuous Bilingual Clinical Coordination Throughout Your Stay

ADVANCED TREATMENT OPTIONS

Key Liver Cancer Treatments

Direct arterial chemotherapy, carbon ion particle beams, and vascular reconstructive surgery for complex tumors.

Direct Artery Infusion (HAIC)

Delivers concentrated medication directly into the liver's tumor-feeding arteries, shrinking large tumors up to 20 times more effectively than regular IV chemo with far fewer side effects.
Learn More

Carbon Ion Particle Therapy

Heavy ion beams that blast tough liver tumors with pin-point accuracy, destroying cancer cells right next to sensitive blood vessels without harming healthy liver tissue.
Learn More

Complex Vascular Surgery

Advanced surgical techniques that remove tumors intertwined with major blood vessels and reconstruct the veins, turning hopeless cases into successful surgeries.
Learn More

WHY CHOOSE US

Why Choose China for Liver Cancer

A specialized clinical pathway connecting international patients directly with world-class hepatobiliary centers in China.

China has established global leadership in advanced liver and bile duct cancer care, pioneering effective conversion regimens that combine Hepatic Arterial Infusion Chemotherapy (HAIC) with targeted therapies and PD-1 immunotherapy to dramatically shrink large or advanced tumors. Chinese tertiary centers perform the highest volume of anatomical liver resections and transplantations globally, offering solutions for complex cases often considered inoperable elsewhere.

Every patient is assigned a personal bilingual clinical coordinator who compiles your scans, blood work (AFP, PIVKA-II), and pathology for a preliminary tumor board review before you leave home. All treatment is billed directly at official hospital rates, with structured remote surveillance and telemedicine check-ins continuing after you return home.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.
Hepatic Arterial Infusion Chemotherapy infuses high-dose medication directly into the liver’s blood supply over 48 hours, concentrating anti-tumor effect up to 200-fold in the tumor while minimizing body-wide toxicity.
Yes. Chinese hepatobiliary centers have developed dedicated conversion regimens pairing HAIC, targeted pills, and immunotherapy with surgical thrombectomy to safely remove advanced vascular invasions.
Carbon ion beams deliver immense, lethal double-strand DNA damage to radioresistant tumors while stopping abruptly before reaching adjacent healthy liver parenchyma or bile ducts.
Our specialized hepatobiliary multidisciplinary board reviews your contrast MRI/CT scans and blood tests within 24 to 48 hours.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage  •  ✓ Direct specialist coordination  •  ✓ 100% Confidential

    Liver Cancer

    There is Only One Thing In The World I Want
    And That Is Hospital.

    Copyright © 2026 PBM Infotech